Merck's Keytruda helps lung cancer patients live longer in trial
Go back to Merck's Keytruda helps lung cancer patients live longer in trial| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,121,761 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.12 -0.46 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.58 | 52 Week High | $77.12 | |||
| Open | $58.88 | 52 Week Low | $49.03 | |||
| Day High | $59.79 | P/E | 38.39 | |||
| Day Low | $58.74 | EPS | $1.54 | |||
| Volume | 9,253,469 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 145.60 +3.22 (2.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.38 | 52 Week High | $65.46 | |||
| Open | $141.37 | 52 Week Low | $47.97 | |||
| Day High | $146.68 | P/E | 99.05 | |||
| Day Low | $141.36 | EPS | $1.47 | |||
| Volume | 9,288,150 | |||||



